• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于单糖的 Toll 样受体 4(TLR4)拮抗剂的结构-活性关系。

Structure-Activity Relationship in Monosaccharide-Based Toll-Like Receptor 4 (TLR4) Antagonists.

机构信息

Department of Biotechnology and Biosciences , University of Milano-Bicocca , Piazza della Scienza, 2 , 20126 Milano , Italy.

Department of Structural & Chemical Biology , Centro de Investigaciones Biologicas, CIB-CSIC , C/Ramiro de Maeztu, 9 , 28040 Madrid , Spain.

出版信息

J Med Chem. 2018 Apr 12;61(7):2895-2909. doi: 10.1021/acs.jmedchem.7b01803. Epub 2018 Mar 12.

DOI:10.1021/acs.jmedchem.7b01803
PMID:29494148
Abstract

The structure-activity relationship was investigated in a series of synthetic TLR4 antagonists formed by a glucosamine core linked to two phosphate esters and two linear carbon chains. Molecular modeling showed that the compounds with 10, 12, and 14 carbons chains are associated with higher stabilization of the MD-2/TLR4 antagonist conformation than in the case of the C16 variant. Binding experiments with human MD-2 showed that the C12 and C14 variants have higher affinity than C10, while the C16 variant did not interact with the protein. The molecules, with the exception of the C16 variant, inhibited the LPS-stimulated TLR4 signal in human and murine cells, and the antagonist potency mirrored the MD-2 affinity calculated from in vitro binding experiments. Fourier-transform infrared, nuclear magnetic resonance, and small angle X-ray scattering measurements suggested that the aggregation state in aqueous solution depends on fatty acid chain lengths and that this property can influence TLR4 activity in this series of compounds.

摘要

研究了一系列通过连接两个磷酸酯和两条线性碳链的氨基葡萄糖核心形成的合成 TLR4 拮抗剂的结构-活性关系。分子建模表明,与 C16 变体相比,具有 10、12 和 14 个碳原子链的化合物与 MD-2/TLR4 拮抗剂构象的更高稳定性相关。与人 MD-2 的结合实验表明,C12 和 C14 变体比 C10 具有更高的亲和力,而 C16 变体与该蛋白不相互作用。除了 C16 变体之外,这些分子均抑制了人源和鼠源细胞中 LPS 刺激的 TLR4 信号,并且拮抗剂效力反映了从体外结合实验计算得出的 MD-2 亲和力。傅里叶变换红外、核磁共振和小角 X 射线散射测量表明,在水溶液中的聚集状态取决于脂肪酸链长,并且该性质可以影响该系列化合物中 TLR4 的活性。

相似文献

1
Structure-Activity Relationship in Monosaccharide-Based Toll-Like Receptor 4 (TLR4) Antagonists.基于单糖的 Toll 样受体 4(TLR4)拮抗剂的结构-活性关系。
J Med Chem. 2018 Apr 12;61(7):2895-2909. doi: 10.1021/acs.jmedchem.7b01803. Epub 2018 Mar 12.
2
Novel carboxylate-based glycolipids: TLR4 antagonism, MD-2 binding and self-assembly properties.新型羧酸酯基糖脂:TLR4 拮抗作用、MD-2 结合和自组装特性。
Sci Rep. 2019 Jan 29;9(1):919. doi: 10.1038/s41598-018-37421-w.
3
Modulation of CD14 and TLR4·MD-2 activities by a synthetic lipid A mimetic.合成脂多糖类似物对 CD14 和 TLR4·MD-2 活性的调节。
Chembiochem. 2014 Jan 24;15(2):250-8. doi: 10.1002/cbic.201300588. Epub 2013 Dec 12.
4
Anti-endotoxic activity and structural basis for human MD-2·TLR4 antagonism of tetraacylated lipid A mimetics based on βGlcN(1↔1)αGlcN scaffold.基于βGlcN(1↔1)αGlcN支架的四酰化类脂A模拟物的人MD-2·TLR4拮抗作用的抗内毒素活性及结构基础。
Innate Immun. 2015 Jul;21(5):490-503. doi: 10.1177/1753425914550426. Epub 2014 Nov 13.
5
Cell activation by monosaccharide lipid A analogues utilizing Toll-like receptor 4.利用Toll样受体4的单糖脂A类似物激活细胞。
Immunology. 2003 Sep;110(1):66-72. doi: 10.1046/j.1365-2567.2003.01709.x.
6
Novel toll-like receptor 4 (TLR4) antagonists identified by structure- and ligand-based virtual screening.基于结构和配体的虚拟筛选鉴定新型 Toll 样受体 4(TLR4)拮抗剂。
Eur J Med Chem. 2013;70:393-9. doi: 10.1016/j.ejmech.2013.10.019. Epub 2013 Oct 12.
7
Dissecting the Innate Immune Recognition of Opioid Inactive Isomer (+)-Naltrexone Derived Toll-like Receptor 4 (TLR4) Antagonists.解析阿片类无活性异构体(+)-纳曲酮衍生的 Toll 样受体 4(TLR4)拮抗剂的先天免疫识别。
J Chem Inf Model. 2018 Apr 23;58(4):816-825. doi: 10.1021/acs.jcim.7b00717. Epub 2018 Apr 11.
8
Amphiphilic Guanidinocalixarenes Inhibit Lipopolysaccharide (LPS)- and Lectin-Stimulated Toll-like Receptor 4 (TLR4) Signaling.两亲性胍基杯[4]芳烃抑制脂多糖 (LPS) 和凝集素刺激的 Toll 样受体 4 (TLR4) 信号通路。
J Med Chem. 2017 Jun 22;60(12):4882-4892. doi: 10.1021/acs.jmedchem.7b00095. Epub 2017 May 15.
9
C4b-binding protein negatively regulates TLR4/MD-2 response but not TLR3 response.C4b结合蛋白负向调节Toll样受体4/髓样分化蛋白2反应,但不调节Toll样受体3反应。
FEBS Lett. 2017 Jun;591(12):1732-1741. doi: 10.1002/1873-3468.12693. Epub 2017 Jun 12.
10
Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran.与内毒素拮抗剂埃瑞托单抗结合的TLR4-MD-2复合物的晶体结构。
Cell. 2007 Sep 7;130(5):906-17. doi: 10.1016/j.cell.2007.08.002.

引用本文的文献

1
Preclinical development of the TLR4 antagonist FP12 as a drug lead targeting the HMGB1/MD-2/TLR4 axis in lethal influenza infection.Toll样受体4拮抗剂FP12作为致死性流感感染中靶向高迁移率族蛋白B1/髓样分化蛋白2/Toll样受体4轴的药物先导物的临床前开发
Innate Immun. 2025 Jan-Dec;31:17534259241313201. doi: 10.1177/17534259241313201.
2
DMEM and EMEM are suitable surrogate media to mimic host environment and expand leptospiral pathogenesis studies using tools.DMEM和EMEM是合适的替代培养基,可用于模拟宿主环境并利用工具扩展钩端螺旋体发病机制研究。
bioRxiv. 2025 Jan 24:2025.01.22.634353. doi: 10.1101/2025.01.22.634353.
3
Development of a New Vaccine Adjuvant System Based on the Combination of the Synthetic TLR4 Agonist FP20 and a Synthetic QS-21 Variant.
基于合成TLR4激动剂FP20与合成QS-21变体组合的新型疫苗佐剂系统的开发
J Med Chem. 2024 Dec 26;67(24):22254-22262. doi: 10.1021/acs.jmedchem.4c02392. Epub 2024 Dec 8.
4
Immunomodulatory of sesquiterpenoids and sesquiterpenoid dimers-based toll-like receptor 4 (TLR4) from Dysoxylum parasiticum stem bark.寄生黄皮茎皮中倍半萜及其倍半萜二聚体的 Toll 样受体 4(TLR4)免疫调节作用。
Sci Rep. 2024 Jul 6;14(1):15597. doi: 10.1038/s41598-024-65829-0.
5
In Vitro Anti-Inflammatory Study of Limonoids Isolated from Plants.从植物中分离出的柠檬苦素的体外抗炎研究
Curr Issues Mol Biol. 2024 Jan 20;46(1):909-922. doi: 10.3390/cimb46010058.
6
Cleaner synthesis of preclinically validated vaccine adjuvants.临床前验证的疫苗佐剂的更清洁合成方法。
Front Chem. 2023 Nov 2;11:1252996. doi: 10.3389/fchem.2023.1252996. eCollection 2023.
7
Lipid A structural diversity among members of the genus .该属成员间脂质A的结构多样性。
Front Microbiol. 2023 May 25;14:1181034. doi: 10.3389/fmicb.2023.1181034. eCollection 2023.
8
Recent Advances in Studying Toll-like Receptors with the Use of Computational Methods.运用计算方法研究 Toll 样受体的最新进展。
J Chem Inf Model. 2023 Jun 26;63(12):3669-3687. doi: 10.1021/acs.jcim.3c00419. Epub 2023 Jun 7.
9
New Glucosamine-Based TLR4 Agonists: Design, Synthesis, Mechanism of Action, and In Vivo Activity as Vaccine Adjuvants.新型基于氨基葡萄糖的 TLR4 激动剂:设计、合成、作用机制及作为疫苗佐剂的体内活性。
J Med Chem. 2023 Feb 23;66(4):3010-3029. doi: 10.1021/acs.jmedchem.2c01998. Epub 2023 Feb 2.
10
Lipopolysaccharide detection by the innate immune system may be an uncommon defence strategy used in nature.先天免疫系统检测脂多糖可能是自然界中一种不常见的防御策略。
Open Biol. 2022 Oct;12(10):220146. doi: 10.1098/rsob.220146. Epub 2022 Oct 5.